James W. Johnson - Concepedia

Author

James W. Johnson

Also Known As

J Johnson, J W JOHNSON, J W Johnson, J. Johnson, J. W. JOHNSON, J. W. Johnson, J.W. Johnson, JAMES JOHNSON, JAMES W. JOHNSON, James Johnson

236

Publications

3.5K

Citations

H-Index

144

Concepts

All Affiliations

Medtronic (United States)Atrium Health Wake Forest Baptist Harvard University Wake Forest University National Institutes of Health

About

James W. Johnson is an author at Medtronic (United States) specializing in medicine, infection control, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	166
2	Health Sciences	6	6	479
3	Education	1	1	16
4	Language Studies	1	1	11
5	Law	1	1	41

James W. Johnson

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity Alana O’Mara, James W. Johnson, Joyce D. Linderman, Journal of Clinical Investigation NutritionMetabolic DisorderHuman Brown FatHyperlipidemiaCaloric Restriction	2020	353
β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance Cristina Aguayo‐Mazzucato, Mark van Haaren, Magdalena Mruk, Cell Metabolism Insulin ResistanceAre InducedDevelopmental BiologyAgingHeterogeneous Distribution	2017	196
Bradycardia Pacing-Induced Short-Long-Short Sequences at the Onset of Ventricular Tachyarrhythmias Michael O. Sweeney, Linda L. Ruetz, Paul Belk, Journal of the American College of Cardiology CardiomyopathyHeart FailureElectrophysiological EvaluationSupraventricular TachycardiaVentricular Tachyarrhythmias	2007	160
Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist Alison S. Baskin, Joyce D. Linderman, Robert J. Brychta, Diabetes	2018	144
Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia James Beardsley, John Williamson, James W. Johnson, CHEST Journal Local Microbiologic DataKlebsiella PneumoniaeHealthcare-associated InfectionHospital EpidemiologyHospital-acquired Pneumonia	2006	140
Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study Gregory W. Woo, Susan Petersen‐Stejskal, James W. Johnson, Journal of Interventional Cardiac Electrophysiology Heart FailureDevice TherapyCardiovascular DiseaseMiracle StudyOutcomes Research	2005	124
Current trends in heart failure readmission rates: analysis of medicare data Juan M. Aranda, James W. Johnson, Jamie B. Conti Clinical Cardiology	2009	118
Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches Michael R. Gold, Robert W. Peters, James W. Johnson, Journal of the American College of Cardiology Heart FailureCardiogenic ShockDevice TherapyCardiac AnaesthesiaSubmuscular Approaches	1996	102
Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis Thomas J. Lester, James W. Johnson, Janet Cuttner The American Journal of Medicine Hematological MalignancyAcute Myelocytic LeukemiaMedicinePulmonary LeukostasisMixed-phenotype Acute Leukemia	1985	102
Predicting the Outcome of Corticoid Therapy for Acute Ulcerative Colitis Samuel Meyers, Paul K. Lerer, Eric J. Feuer, Journal of Clinical Gastroenterology InflammationChronic Inflammatory DiseasesFunctional Gastrointestinal DisorderRemission RateGastroenterology	1987	98

Page 1